1	Colgate	_	NNP	_	_	2	NAME	_	_
2	Palmolive	_	NNP	_	_	4	SBJ	_	_
3	Co.	_	NNP	_	_	2	POSTHON	_	_
4	reported	_	VBD	_	_	0	ROOT	_	_
5	third-quarter	_	JJ	_	_	7	NMOD	_	_
6	net	_	JJ	_	_	7	NMOD	_	_
7	income	_	NN	_	_	8	SBJ	_	_
8	rose	_	VBD	_	_	4	OBJ	_	_
9	27	_	CD	_	_	10	NMOD	_	_
10	%	_	NN	_	_	8	EXT	_	_
11	,	_	,	_	_	8	P	_	_
12	bolstered	_	VBN	_	_	8	ADV	_	_
13	by	_	IN	_	_	12	LGS	_	_
14	strong	_	JJ	_	_	15	NMOD	_	_
15	sales	_	NNS	_	_	13	PMOD	_	_
16	in	_	IN	_	_	15	LOC	_	_
17	its	_	PRP$	_	_	20	NMOD	_	_
18	Latin	_	JJ	_	_	19	AMOD	_	_
19	American	_	JJ	_	_	20	NMOD	_	_
20	business	_	NN	_	_	16	PMOD	_	_
21	and	_	CC	_	_	15	COORD	_	_
22	surprisingly	_	RB	_	_	23	AMOD	_	_
23	healthy	_	JJ	_	_	24	NMOD	_	_
24	profits	_	NNS	_	_	21	CONJ	_	_
25	from	_	IN	_	_	24	NMOD	_	_
26	U.S.	_	NNP	_	_	27	NMOD	_	_
27	operations	_	NNS	_	_	25	PMOD	_	_
28	.	_	.	_	_	4	P	_	_

1	Colgate	_	NNP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	net	_	JJ	_	_	4	NMOD	_	_
4	income	_	NN	_	_	8	SBJ	_	_
5	for	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	quarter	_	NN	_	_	5	PMOD	_	_
8	rose	_	VBD	_	_	2	OBJ	_	_
9	to	_	TO	_	_	8	DIR	_	_
10	$	_	$	_	_	9	PMOD	_	_
11	76.7	_	CD	_	_	10	DEP	_	_
12	million	_	CD	_	_	10	DEP	_	_
13	,	_	,	_	_	10	P	_	_
14	or	_	CC	_	_	10	COORD	_	_
15	$	_	$	_	_	14	CONJ	_	_
16	1.06	_	CD	_	_	15	NMOD	_	_
17	a	_	DT	_	_	18	NMOD	_	_
18	share	_	NN	_	_	15	ADV	_	_
19	,	_	,	_	_	8	P	_	_
20	on	_	IN	_	_	8	ADV	_	_
21	sales	_	NNS	_	_	20	PMOD	_	_
22	that	_	WDT	_	_	23	SBJ	_	_
23	increased	_	VBD	_	_	21	NMOD	_	_
24	6	_	CD	_	_	25	NMOD	_	_
25	%	_	NN	_	_	23	EXT	_	_
26	to	_	TO	_	_	23	DIR	_	_
27	$	_	$	_	_	26	PMOD	_	_
28	1.3	_	CD	_	_	27	DEP	_	_
29	billion	_	CD	_	_	27	DEP	_	_
30	.	_	.	_	_	2	P	_	_

1	In	_	IN	_	_	7	TMP	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	year-earlier	_	JJ	_	_	4	NMOD	_	_
4	period	_	NN	_	_	1	PMOD	_	_
5	,	_	,	_	_	7	P	_	_
6	Colgate	_	NNP	_	_	7	SBJ	_	_
7	posted	_	VBD	_	_	0	ROOT	_	_
8	net	_	JJ	_	_	9	NMOD	_	_
9	income	_	NN	_	_	7	OBJ	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	$	_	$	_	_	10	PMOD	_	_
12	60.2	_	CD	_	_	11	DEP	_	_
13	million	_	CD	_	_	11	DEP	_	_
14	,	_	,	_	_	11	P	_	_
15	or	_	CC	_	_	11	COORD	_	_
16	88	_	CD	_	_	17	NMOD	_	_
17	cents	_	NNS	_	_	15	CONJ	_	_
18	a	_	DT	_	_	19	NMOD	_	_
19	share	_	NN	_	_	17	ADV	_	_
20	.	_	.	_	_	7	P	_	_

1	Last	_	JJ	_	_	2	NMOD	_	_
2	year	_	NN	_	_	4	NMOD	_	_
3	's	_	POS	_	_	2	SUFFIX	_	_
4	results	_	NNS	_	_	5	SBJ	_	_
5	included	_	VBD	_	_	0	ROOT	_	_
6	earnings	_	NNS	_	_	5	OBJ	_	_
7	from	_	IN	_	_	6	NMOD	_	_
8	discontinued	_	VBN	_	_	9	NMOD	_	_
9	operations	_	NNS	_	_	7	PMOD	_	_
10	of	_	IN	_	_	6	NMOD	_	_
11	$	_	$	_	_	10	PMOD	_	_
12	13.1	_	CD	_	_	11	DEP	_	_
13	million	_	CD	_	_	11	DEP	_	_
14	,	_	,	_	_	11	P	_	_
15	or	_	CC	_	_	11	COORD	_	_
16	19	_	CD	_	_	17	NMOD	_	_
17	cents	_	NNS	_	_	15	CONJ	_	_
18	a	_	DT	_	_	19	NMOD	_	_
19	share	_	NN	_	_	17	ADV	_	_
20	.	_	.	_	_	5	P	_	_

1	Reuben	_	NNP	_	_	2	NAME	_	_
2	Mark	_	NNP	_	_	12	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	chairman	_	NN	_	_	2	APPO	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	chief	_	JJ	_	_	8	NMOD	_	_
7	executive	_	JJ	_	_	8	NMOD	_	_
8	officer	_	NN	_	_	5	CONJ	_	_
9	of	_	IN	_	_	4	NMOD	_	_
10	Colgate	_	NNP	_	_	9	PMOD	_	_
11	,	_	,	_	_	2	P	_	_
12	said	_	VBD	_	_	0	ROOT	_	_
13	earnings	_	NN	_	_	14	NMOD	_	_
14	growth	_	NN	_	_	15	SBJ	_	_
15	was	_	VBD	_	_	12	OBJ	_	_
16	fueled	_	VBN	_	_	15	VC	_	_
17	by	_	IN	_	_	16	LGS	_	_
18	strong	_	JJ	_	_	19	NMOD	_	_
19	sales	_	NNS	_	_	17	PMOD	_	_
20	in	_	IN	_	_	19	LOC	_	_
21	Latin	_	NNP	_	_	22	NAME	_	_
22	America	_	NNP	_	_	20	PMOD	_	_
23	,	_	,	_	_	22	P	_	_
24	the	_	DT	_	_	26	NMOD	_	_
25	Far	_	NNP	_	_	26	NAME	_	_
26	East	_	NNP	_	_	22	COORD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	Europe	_	NNP	_	_	27	CONJ	_	_
29	.	_	.	_	_	12	P	_	_

1	Results	_	NNS	_	_	2	SBJ	_	_
2	were	_	VBD	_	_	22	OBJ	_	_
3	also	_	RB	_	_	2	ADV	_	_
4	bolstered	_	VBN	_	_	2	VC	_	_
5	by	_	IN	_	_	4	LGS	_	_
6	``	_	``	_	_	5	P	_	_
7	a	_	DT	_	_	10	NMOD	_	_
8	very	_	RB	_	_	9	AMOD	_	_
9	meaningful	_	JJ	_	_	10	NMOD	_	_
10	increase	_	NN	_	_	5	PMOD	_	_
11	in	_	IN	_	_	10	LOC	_	_
12	operating	_	NN	_	_	13	NMOD	_	_
13	profit	_	NN	_	_	11	PMOD	_	_
14	at	_	IN	_	_	10	LOC	_	_
15	Colgate	_	NNP	_	_	18	NMOD	_	_
16	's	_	POS	_	_	15	SUFFIX	_	_
17	U.S.	_	NNP	_	_	18	NMOD	_	_
18	business	_	NN	_	_	14	PMOD	_	_
19	,	_	,	_	_	22	P	_	_
20	''	_	''	_	_	22	P	_	_
21	he	_	PRP	_	_	22	SBJ	_	_
22	said	_	VBD	_	_	0	ROOT	_	_
23	.	_	.	_	_	22	P	_	_

1	Operating	_	NN	_	_	2	NMOD	_	_
2	profit	_	NN	_	_	27	SBJ	_	_
3	at	_	IN	_	_	2	LOC	_	_
4	Colgate	_	NNP	_	_	8	NMOD	_	_
5	's	_	POS	_	_	4	SUFFIX	_	_
6	U.S.	_	NNP	_	_	8	NMOD	_	_
7	household	_	NN	_	_	8	NMOD	_	_
8	products	_	NNS	_	_	3	PMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	personal	_	JJ	_	_	12	NMOD	_	_
11	care	_	NN	_	_	12	NMOD	_	_
12	businesses	_	NNS	_	_	9	CONJ	_	_
13	,	_	,	_	_	8	P	_	_
14	which	_	WDT	_	_	15	SBJ	_	_
15	include	_	VBP	_	_	8	NMOD	_	_
16	such	_	JJ	_	_	18	NMOD	_	_
17	well-known	_	JJ	_	_	18	NMOD	_	_
18	brands	_	NNS	_	_	15	OBJ	_	_
19	as	_	IN	_	_	18	NMOD	_	_
20	Colgate	_	NNP	_	_	21	NMOD	_	_
21	toothpaste	_	NN	_	_	19	PMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	Fab	_	NNP	_	_	25	NMOD	_	_
24	laundry	_	NN	_	_	25	NMOD	_	_
25	detergent	_	NN	_	_	22	CONJ	_	_
26	,	_	,	_	_	8	P	_	_
27	jumped	_	VBD	_	_	35	OBJ	_	_
28	more	_	RBR	_	_	30	DEP	_	_
29	than	_	IN	_	_	30	DEP	_	_
30	40	_	CD	_	_	31	NMOD	_	_
31	%	_	NN	_	_	27	EXT	_	_
32	,	_	,	_	_	35	P	_	_
33	the	_	DT	_	_	34	NMOD	_	_
34	company	_	NN	_	_	35	SBJ	_	_
35	said	_	VBD	_	_	0	ROOT	_	_
36	.	_	.	_	_	35	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Mark	_	NNP	_	_	3	SBJ	_	_
3	attributed	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	improvement	_	NN	_	_	3	OBJ	_	_
6	to	_	TO	_	_	3	ADV	_	_
7	cost	_	NN	_	_	8	NMOD	_	_
8	savings	_	NNS	_	_	6	PMOD	_	_
9	achieved	_	VBN	_	_	8	APPO	_	_
10	by	_	IN	_	_	9	MNR	_	_
11	consolidating	_	VBG	_	_	10	PMOD	_	_
12	manufacturing	_	VBG	_	_	13	NMOD	_	_
13	operations	_	NNS	_	_	11	OBJ	_	_
14	,	_	,	_	_	11	P	_	_
15	blending	_	VBG	_	_	11	COORD	_	_
16	together	_	RB	_	_	15	ADV	_	_
17	two	_	CD	_	_	19	NMOD	_	_
18	sales	_	NNS	_	_	19	NMOD	_	_
19	organizations	_	NNS	_	_	15	OBJ	_	_
20	and	_	CC	_	_	15	COORD	_	_
21	more	_	RBR	_	_	22	AMOD	_	_
22	carefully	_	RB	_	_	23	MNR	_	_
23	focusing	_	VBG	_	_	20	CONJ	_	_
24	the	_	DT	_	_	25	NMOD	_	_
25	company	_	NN	_	_	28	NMOD	_	_
26	's	_	POS	_	_	25	SUFFIX	_	_
27	promotional	_	JJ	_	_	28	NMOD	_	_
28	activities	_	NNS	_	_	23	OBJ	_	_
29	.	_	.	_	_	3	P	_	_

1	``	_	``	_	_	25	P	_	_
2	We	_	PRP	_	_	3	SBJ	_	_
3	've	_	VBP	_	_	25	DEP	_	_
4	done	_	VBN	_	_	3	VC	_	_
5	a	_	DT	_	_	6	NMOD	_	_
6	lot	_	NN	_	_	4	OBJ	_	_
7	to	_	TO	_	_	4	PRP	_	_
8	improve	_	VB	_	_	7	IM	_	_
9	(	_	(	_	_	10	P	_	_
10	U.S.	_	NNP	_	_	13	PRN	_	_
11	.	_	.	_	_	10	P	_	_
12	)	_	)	_	_	10	P	_	_
13	results	_	NNS	_	_	8	OBJ	_	_
14	and	_	CC	_	_	3	COORD	_	_
15	a	_	DT	_	_	16	NMOD	_	_
16	lot	_	NN	_	_	18	SBJ	_	_
17	more	_	JJR	_	_	16	NMOD	_	_
18	will	_	MD	_	_	14	CONJ	_	_
19	be	_	VB	_	_	18	VC	_	_
20	done	_	VBN	_	_	19	VC	_	_
21	,	_	,	_	_	25	P	_	_
22	''	_	''	_	_	25	P	_	_
23	Mr.	_	NNP	_	_	24	TITLE	_	_
24	Mark	_	NNP	_	_	25	SBJ	_	_
25	said	_	VBD	_	_	0	ROOT	_	_
26	.	_	.	_	_	25	P	_	_

1	``	_	``	_	_	7	P	_	_
2	Improving	_	NN	_	_	3	NMOD	_	_
3	profitability	_	NN	_	_	7	SBJ	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	U.S.	_	NNP	_	_	6	NMOD	_	_
6	operations	_	NNS	_	_	4	PMOD	_	_
7	is	_	VBZ	_	_	0	ROOT	_	_
8	an	_	DT	_	_	11	NMOD	_	_
9	extremely	_	RB	_	_	10	AMOD	_	_
10	high	_	JJ	_	_	11	NMOD	_	_
11	priority	_	NN	_	_	7	PRD	_	_
12	in	_	IN	_	_	7	LOC	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	company	_	NN	_	_	12	PMOD	_	_
15	.	_	.	_	_	7	P	_	_
16	''	_	''	_	_	7	P	_	_

1	Colgate	_	NNP	_	_	3	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	results	_	NNS	_	_	4	SBJ	_	_
4	were	_	VBD	_	_	0	ROOT	_	_
5	at	_	IN	_	_	4	LOC-PRD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	high	_	JJ	_	_	8	NMOD	_	_
8	end	_	NN	_	_	5	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	range	_	NN	_	_	9	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	analysts	_	NNS	_	_	15	NMOD	_	_
14	'	_	POS	_	_	13	SUFFIX	_	_
15	forecasts	_	NNS	_	_	12	PMOD	_	_
16	.	_	.	_	_	4	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	scope	_	NN	_	_	10	SBJ	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	improvement	_	NN	_	_	3	PMOD	_	_
6	in	_	IN	_	_	5	LOC	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	U.S.	_	NNP	_	_	9	NMOD	_	_
9	business	_	NN	_	_	6	PMOD	_	_
10	caught	_	VBD	_	_	0	ROOT	_	_
11	some	_	DT	_	_	12	NMOD	_	_
12	analysts	_	NNS	_	_	10	OBJ	_	_
13	by	_	IN	_	_	10	ADV	_	_
14	surprise	_	NN	_	_	13	PMOD	_	_
15	.	_	.	_	_	10	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	company	_	NN	_	_	5	NMOD	_	_
3	's	_	POS	_	_	2	SUFFIX	_	_
4	domestic	_	JJ	_	_	5	NMOD	_	_
5	business	_	NN	_	_	13	SBJ	_	_
6	,	_	,	_	_	5	P	_	_
7	especially	_	RB	_	_	11	NMOD	_	_
8	its	_	PRP$	_	_	11	NMOD	_	_
9	household	_	NN	_	_	11	NMOD	_	_
10	products	_	NNS	_	_	11	NMOD	_	_
11	division	_	NN	_	_	5	APPO	_	_
12	,	_	,	_	_	5	P	_	_
13	has	_	VBZ	_	_	0	ROOT	_	_
14	performed	_	VBN	_	_	13	VC	_	_
15	poorly	_	RB	_	_	14	MNR	_	_
16	for	_	IN	_	_	14	TMP	_	_
17	years	_	NNS	_	_	16	PMOD	_	_
18	.	_	.	_	_	13	P	_	_

1	Analysts	_	NNS	_	_	2	SBJ	_	_
2	say	_	VBP	_	_	0	ROOT	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	earnings	_	NNS	_	_	5	NMOD	_	_
5	improvement	_	NN	_	_	6	SBJ	_	_
6	came	_	VBD	_	_	2	OBJ	_	_
7	from	_	IN	_	_	6	DIR	_	_
8	cutting	_	VBG	_	_	7	PMOD	_	_
9	costs	_	NNS	_	_	8	OBJ	_	_
10	rather	_	RB	_	_	8	COORD	_	_
11	than	_	IN	_	_	10	DEP	_	_
12	increasing	_	VBG	_	_	10	CONJ	_	_
13	sales	_	NNS	_	_	12	OBJ	_	_
14	.	_	.	_	_	2	P	_	_

1	For	_	IN	_	_	7	ADV	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	nine	_	CD	_	_	4	NMOD	_	_
4	months	_	NNS	_	_	1	PMOD	_	_
5	,	_	,	_	_	7	P	_	_
6	net	_	JJ	_	_	7	SBJ	_	_
7	increased	_	VBD	_	_	0	ROOT	_	_
8	14	_	CD	_	_	9	NMOD	_	_
9	%	_	NN	_	_	7	EXT	_	_
10	to	_	TO	_	_	7	DIR	_	_
11	$	_	$	_	_	10	PMOD	_	_
12	217.5	_	CD	_	_	11	DEP	_	_
13	million	_	CD	_	_	11	DEP	_	_
14	,	_	,	_	_	11	P	_	_
15	or	_	CC	_	_	11	COORD	_	_
16	$	_	$	_	_	15	CONJ	_	_
17	3.09	_	CD	_	_	16	NMOD	_	_
18	a	_	DT	_	_	19	NMOD	_	_
19	share	_	NN	_	_	16	ADV	_	_
20	.	_	.	_	_	7	P	_	_

1	Sales	_	NNS	_	_	2	SBJ	_	_
2	rose	_	VBD	_	_	0	ROOT	_	_
3	7	_	CD	_	_	4	NMOD	_	_
4	%	_	NN	_	_	2	EXT	_	_
5	to	_	TO	_	_	2	DIR	_	_
6	$	_	$	_	_	5	PMOD	_	_
7	3.8	_	CD	_	_	6	DEP	_	_
8	billion	_	CD	_	_	6	DEP	_	_
9	.	_	.	_	_	2	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	company	_	NN	_	_	3	SBJ	_	_
3	earned	_	VBD	_	_	0	ROOT	_	_
4	$	_	$	_	_	3	OBJ	_	_
5	191.1	_	CD	_	_	4	DEP	_	_
6	million	_	CD	_	_	4	DEP	_	_
7	,	_	,	_	_	4	P	_	_
8	or	_	CC	_	_	4	COORD	_	_
9	$	_	$	_	_	8	CONJ	_	_
10	2.79	_	CD	_	_	9	NMOD	_	_
11	a	_	DT	_	_	12	NMOD	_	_
12	share	_	NN	_	_	9	ADV	_	_
13	,	_	,	_	_	3	P	_	_
14	in	_	IN	_	_	3	TMP	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	year-earlier	_	JJ	_	_	17	NMOD	_	_
17	period	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	3	P	_	_

1	Colgate	_	NNP	_	_	5	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	1988	_	CD	_	_	5	NMOD	_	_
4	net	_	JJ	_	_	5	NMOD	_	_
5	income	_	NN	_	_	6	SBJ	_	_
6	included	_	VBD	_	_	0	ROOT	_	_
7	$	_	$	_	_	6	OBJ	_	_
8	40.1	_	CD	_	_	7	DEP	_	_
9	million	_	CD	_	_	7	DEP	_	_
10	,	_	,	_	_	7	P	_	_
11	or	_	CC	_	_	7	COORD	_	_
12	59	_	CD	_	_	13	NMOD	_	_
13	cents	_	NNS	_	_	11	CONJ	_	_
14	a	_	DT	_	_	15	NMOD	_	_
15	share	_	NN	_	_	13	ADV	_	_
16	,	_	,	_	_	7	P	_	_
17	from	_	IN	_	_	7	NMOD	_	_
18	discontinued	_	VBN	_	_	19	NMOD	_	_
19	operations	_	NNS	_	_	17	PMOD	_	_
20	.	_	.	_	_	6	P	_	_

1	Colgate	_	NNP	_	_	2	SBJ	_	_
2	sold	_	VBD	_	_	0	ROOT	_	_
3	its	_	PRP$	_	_	5	NMOD	_	_
4	hospital	_	NN	_	_	5	NMOD	_	_
5	supply	_	NN	_	_	2	OBJ	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	home	_	NN	_	_	10	NMOD	_	_
8	health	_	NN	_	_	10	NMOD	_	_
9	care	_	NN	_	_	10	NMOD	_	_
10	business	_	NN	_	_	6	CONJ	_	_
11	last	_	JJ	_	_	12	NMOD	_	_
12	year	_	NN	_	_	2	TMP	_	_
13	.	_	.	_	_	2	P	_	_

1	Separately	_	RB	_	_	5	ADV	_	_
2	,	_	,	_	_	5	P	_	_
3	Colgate	_	NNP	_	_	5	SBJ	_	_
4	Wednesday	_	NNP	_	_	5	TMP	_	_
5	finalized	_	VBD	_	_	0	ROOT	_	_
6	an	_	DT	_	_	7	NMOD	_	_
7	agreement	_	NN	_	_	5	OBJ	_	_
8	with	_	IN	_	_	7	NMOD	_	_
9	MacroChem	_	NNP	_	_	8	PMOD	_	_
10	Corp.	_	NNP	_	_	9	POSTHON	_	_
11	,	_	,	_	_	9	P	_	_
12	a	_	DT	_	_	18	NMOD	_	_
13	tiny	_	JJ	_	_	18	NMOD	_	_
14	dental	_	JJ	_	_	18	NMOD	_	_
15	products	_	NNS	_	_	14	COORD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	pharmaceutical	_	JJ	_	_	16	CONJ	_	_
18	concern	_	NN	_	_	9	APPO	_	_
19	based	_	VBN	_	_	18	APPO	_	_
20	in	_	IN	_	_	19	LOC	_	_
21	Billerica	_	NNP	_	_	20	PMOD	_	_
22	,	_	,	_	_	21	P	_	_
23	Mass.	_	NNP	_	_	21	APPO	_	_
24	,	_	,	_	_	21	P	_	_
25	to	_	TO	_	_	7	NMOD	_	_
26	market	_	VB	_	_	25	IM	_	_
27	in	_	IN	_	_	26	LOC	_	_
28	the	_	DT	_	_	29	NMOD	_	_
29	U.S.	_	NNP	_	_	27	PMOD	_	_
30	four	_	CD	_	_	26	OBJ	_	_
31	of	_	IN	_	_	30	NMOD	_	_
32	MacroChem	_	NNP	_	_	36	NMOD	_	_
33	's	_	POS	_	_	32	SUFFIX	_	_
34	FDA-approved	_	JJ	_	_	36	NMOD	_	_
35	dental	_	JJ	_	_	36	NMOD	_	_
36	products	_	NNS	_	_	31	PMOD	_	_
37	.	_	.	_	_	5	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	products	_	NNS	_	_	13	SBJ	_	_
3	--	_	:	_	_	2	P	_	_
4	sealants	_	NNS	_	_	2	APPO	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	bonding	_	NN	_	_	7	NMOD	_	_
7	materials	_	NNS	_	_	5	CONJ	_	_
8	used	_	VBN	_	_	4	APPO	_	_
9	by	_	IN	_	_	8	LGS	_	_
10	dentists	_	NNS	_	_	9	PMOD	_	_
11	--	_	:	_	_	2	P	_	_
12	all	_	DT	_	_	13	DEP	_	_
13	contain	_	VBP	_	_	0	ROOT	_	_
14	fluoride	_	NN	_	_	13	OBJ	_	_
15	that	_	WDT	_	_	16	SBJ	_	_
16	is	_	VBZ	_	_	14	NMOD	_	_
17	released	_	VBN	_	_	16	VC	_	_
18	over	_	IN	_	_	17	TMP	_	_
19	time	_	NN	_	_	18	PMOD	_	_
20	.	_	.	_	_	13	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	move	_	NN	_	_	3	SBJ	_	_
3	is	_	VBZ	_	_	19	OBJ	_	_
4	part	_	NN	_	_	3	PRD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	a	_	DT	_	_	7	NMOD	_	_
7	drive	_	NN	_	_	5	PMOD	_	_
8	to	_	TO	_	_	7	NMOD	_	_
9	increase	_	VB	_	_	8	IM	_	_
10	Colgate	_	NNP	_	_	12	NMOD	_	_
11	's	_	POS	_	_	10	SUFFIX	_	_
12	business	_	NN	_	_	9	OBJ	_	_
13	with	_	IN	_	_	12	NMOD	_	_
14	dentists	_	NNS	_	_	13	PMOD	_	_
15	,	_	,	_	_	19	P	_	_
16	a	_	DT	_	_	18	NMOD	_	_
17	company	_	NN	_	_	18	NMOD	_	_
18	spokeswoman	_	NN	_	_	19	SBJ	_	_
19	said	_	VBD	_	_	0	ROOT	_	_
20	.	_	.	_	_	19	P	_	_

1	Terms	_	NNS	_	_	5	SBJ	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	agreement	_	NN	_	_	2	PMOD	_	_
5	were	_	VBD	_	_	0	ROOT	_	_
6	n't	_	RB	_	_	5	ADV	_	_
7	given	_	VBN	_	_	5	VC	_	_
8	.	_	.	_	_	5	P	_	_

